After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
This article presents Ways To Enhance Your Budgeting Strategy with incremental tweaks, monitoring, and alignment to goals.
21,926 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
A provocative jailbreak method exposed a flaw in AI chatbots, prompting researchers to rethink safety guardrails. Thi...
Brokers are turning to AI-enabled property management as market forces slow home sales, embracing recurring revenue t...
As urban cores recalibrate, the federal Historic Rehabilitation Tax Credit offers a 20% credit over five years to fun...
A couple faces a surprise $4,000 wedding debt after in-laws attach a repayment clause, prompting a warning about how ...
A surge in 2024 five-percent CDs is quietly lifting Medicare premiums in 2026 through IRMAA, due to income reported t...
Midday action hinges on Alphabet's report and the AI spend cycle. Learn what moves markets, how hyperscalers shape ri...
Travel demand is shifting, and investors are watching choice hotels (chh) 2025 with keen interest. This article break...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
A rally in Cava lifted the restaurant group, but Sweetgreen’s disappointing sales offer pulled markets back, undersco...
In February 2026, Beyond Meat shares surged roughly 24%, propelled by optimism around product expansion and earnings ...
A new CBO forecast shows tariffs being rolled back would widen the deficit by about $2 trillion over 2026-2036, yet t...